For the quarter ending 2026-03-31, QTTB has $63,675K in assets. $17,362K in debts. $50,751K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 50,751 | 48,297 | 49,039 | 54,832 |
| Prepaid expenses and other current assets | 6,451 | 6,753 | 1,771 | 3,492 |
| Total current assets | 57,202 | 55,050 | 50,810 | 58,324 |
| Equity investment | - | 0 | 0 | 0 |
| Total property and equipment | 2,823 | 2,823 | 2,823 | - |
| Less accumulated depreciation | 1,934 | 1,844 | 1,754 | - |
| Other noncurrent assets | - | 0 | 0 | 570 |
| Property and equipment, net | 889 | 979 | 1,069 | 1,160 |
| Right-of-use asset, operating leases | 4,937 | 5,100 | 5,258 | 5,416 |
| Restricted cash and restricted cash equivalents | 647 | 647 | 647 | 647 |
| Total assets | 63,675 | 61,776 | 57,784 | 66,117 |
| Accounts payable | 653 | 879 | 973 | 910 |
| Cvr liability | - | 0 | 0 | 0 |
| Accrued expenses and other current liabilities | 3,777 | 4,232 | 3,905 | 4,396 |
| Venture debt, current portion | 6,239 | 6,235 | 6,232 | 6,228 |
| Total current liabilities | 10,669 | 11,346 | 11,110 | 11,534 |
| Other noncurrent liabilities | - | 0 | 55,000 | 55,000 |
| Lease liability, net of current portion | 4,754 | 4,943 | 5,121 | 5,296 |
| Venture debt, net of current portion | 1,939 | 3,473 | 5,001 | 6,522 |
| Total liabilities | 17,362 | 19,762 | 76,232 | 78,352 |
| Common stock, 0.0001 par value 400,000,000 shares authorized, 14,629,463 and 12,858,047 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 2 | 2 | 2 | 2 |
| Additional paid-in capital | 258,913 | 247,005 | 244,273 | 243,097 |
| Accumulated other comprehensive gain (loss) | - | - | 0 | 0 |
| Accumulated deficit | -212,602 | -204,993 | -262,723 | -255,334 |
| Total stockholders' equity | 46,313 | 42,014 | -18,448 | -12,235 |
| Total liabilities and stockholders' equity | 63,675 | 61,776 | 57,784 | 66,117 |
Q32 Bio Inc. (QTTB)
Q32 Bio Inc. (QTTB)